Posters—Alphabetical by presenting author P1 Evaluation of impact of addition of Digital Breast Tomosynthesis (DBT) in diagnostic workup of breast lesions of uncertain malignant potential (R-3) Dr Nadia Akhtar 1 1Northampton General Hospital NHS Trust, Northampton, England Breast Cancer Research 25...
Helping Others Deal with Cancer; in Association with the NHS as Part of Breast Cancer Awareness Month, Survivor Anne Dixon Talks Candidly to Reporter VICKI NEWMAN about Her Battle against the IllnessWHEN 43-year-old Anne Dixon found a lump on her breast she told herself it was just a cyst,...
19 June 2007 © 2007 BioMed Central Ltd Speaker Abstracts Introduction S1 Assessing prognosis for early breast cancer: clinical versus genetic profiles GN Hortobagyi Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Breast Cancer Research 2007...
Clinic and research staff approach patients directly and posters and leaflets are placed in waiting rooms so that patients can opt in themselves. Nonetheless, the sample might not be representative of symptomatic breast cancer patients in general and we cannot know how many people were made aware ...
HT&Me is a blended supported self-management intervention which seeks to encourage adherence to AET and improve QoL in women with ER + breast cancer, while being scalable and implementable within the UK National Health Service (NHS). Here we describe: the intervention development process; ...
Trastuzumab is a monoclonal antibody used in the treatment of breast cancer in cases where the tumor overexpresses the HER2 receptor, a cell membrane receptor activated by the epidermal growth factor. Intravenous and subcutaneous administration of trastuzumab have comparable clinical and pharmacological cha...
Public information and awareness campaigns for primary cancer prevention seem to be more common in the States with a universal health service and in Mediterranean countries (Table 2). Organized BC screening programmes are active in all HI OECD countries except Greece, Czech Republic, Slovakia, and ...
Breast cancer (BC) currently occupies the second rank in cancer-related global female deaths. Although consistent awareness and improved diagnosis have reduced mortality in recent years, late diagnosis and resistant response still limit the therapeutic e